About AVT
Browse Articles
Customer Services

Current Issue

Displaying 11 results:

Short communication

Raltegravir plus two nucleoside analogues as combination antiretroviral therapy in HIV-infected patients who require cancer chemotherapy

José L Casado, Isabel Machuca, Sara Bañón, Ana Moreno, José Moltó, Miguel A Rodriguez

Antiviral Therapy 2015; 20:773-777

Original article

Twelve-year mortality in HIV-infected patients receiving antiretroviral therapy: the role of social vulnerability. The ANRS CO8 APROCO-COPILOTE cohort

Camelia Protopopescu, François Raffi, Bruno Spire, Lucile Hardel, Christian Michelet, Christine Cheneau, Vincent Le Moing, Catherine Leport, Maria Patrizia Carrieri, the ANRS CO8 APROCO-COPILOTE Study Group

Antiviral Therapy 2015; 20:763-772

Original article

Use of neuraminidase inhibitors in primary health care during pandemic and seasonal influenza between 2009 and 2013

Thierry Blanchon, Félicité Geffrier, Clément Turbelin, Isabelle Daviaud, Cédric Laouénan, Xavier Duval, Bruno Lambert, Thomas Hanslik, Anne Mosnier, Catherine Leport

Antiviral Therapy 2015; 20:753-761

Original article

In vitro evaluation of antiviral activity of tea seed saponins against porcine reproductive and respiratory syndrome virus

E Li, Na Sun, Jun-Xing Zhao, Yao-Gui Sun, Jian-Gang Huang, Hai-Min Lei, Jian-Hua Guo, Yuan-Liang Hu, Wen-Kui Wang, Hong-Quan Li

Antiviral Therapy 2015; 20:743-752

Original article

Loss to follow-up in the Australian HIV Observational Database

Hamish McManus, Kathy Petoumenos, Katherine Brown, David Baker, Darren Russell, Tim Read, Don Smith, Lynne Wray, Michelle Giles, Jennifer Hoy, Andrew Carr, Matthew G Law, the Australian HIV Observational Database

Antiviral Therapy 2015; 20:731-741

Original article

Post-marketing experience with nevirapine extended release (XR) tablets: effectiveness and tolerability in a population-based cohort in British Columbia, Canada

Katherine J Lepik, Benita Yip, Rachel A McGovern, Erin Ding, Adriana Nohpal, Birgit E Watson, Junine Toy, Linda Akagi, P Richard Harrigan, David M Moore, Robert S Hogg, Julio SG Montaner, Rolando Barrios

Antiviral Therapy 2015; 20:721-730

Original article

Single dose peramivir for the treatment of acute seasonal influenza: integrated analysis of efficacy and safety from two placebo-controlled trials

Richard Whitley, Alan Laughlin, Simon Carson, Essack Mitha, Guy Tellier, Mark Stich, Jenna Elder, W James Alexander, Sylvia Dobo, Phil Collis, William P Sheridan

Antiviral Therapy 2015; 20:709-719

Original article

Safety, pharmacokinetics and pharmacodynamics of the oral toll-like receptor 7 agonist GS-9620 in treatment-naive patients with chronic hepatitis C

Eric Lawitz, Daniel Gruener, Thomas Marbury, John Hill, Lynn Webster, David Hassman, Anh-Hoa Nguyen, Stefan Pflanz, Erik Mogalian, Anuj Gaggar, Benedetta Massetto, G Mani Subramanian, John G McHutchison, Ira M Jacobson, Bradley Freilich, Maribel Rodriguez-Torres

Antiviral Therapy 2015; 20:699-708

Original article

A randomized study of standard versus double dose oseltamivir for treating influenza in the community

Rashmi Dixit, Gulam Khandaker, Peter Hay, Kenneth McPhie, Janette Taylor, Harunor Rashid, Leon Heron, Dominic Dwyer, Robert Booy

Antiviral Therapy 2015; 20:689-698

Original article

Efficacy of tenofovir disoproxil fumarate to prevent vertical transmission in mothers with lamivudine-resistant HBV

Jing Wang, Jinfeng Liu, Caijing Qi, Taotao Yan, Furong Cao, Li Jin, Yingli He, Yuan Yang, Shulin Zhang, Tianyan Chen, Yingren Zhao

Antiviral Therapy 2015; 20:681-687

Copyright © Nucleus Global 2016. Part of Nucleus Global.
Design and Technology by Nucleus Global
Company registration No. 321 0712 (England & Wales). Registered Office address: Admiral House 76-78 Old Street, London EC1V 9AZ.